Time October 17, 2019
Jamie Ducharme

The field of genetics has come a long way since human genome sequencing began in the 1990s—but it still has massive room for growth, 23andMe co-founder Anne Wojcicki said at the TIME 100 Health Summit on Thursday.

Wojcicki appeared on a panel about DNA and genetics with geneticist Eric Lander, president and founding director of the Broad Institute of MIT and Harvard. During the conversation, Wojcicki likened lingering concerns over privacy issues associated with at-home genetic testing—like that which 23andMe provides through its direct-to-consumer saliva tests—to decades-ago hesitance to put credit card information online, which she experienced at the time as an investor on Wall Street. The arrest of the suspected Golden State Killer, which relied on genetic data uploaded...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Patient / Consumer, Precision Medicine, Privacy / Security, Provider, Technology, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article